Bayer bosses facing shareholder reckoning over Monsanto deal as cancer lawsuits mount
A growing number of shareholders have said they won’t support executives and supervisory board members in the upcoming no-confidence vote. The vote has no legal weight but a low enough approval rating could be risky for the future of CEO Werner Baumann and ot…
bubmagApril 24, 2019